Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionariesin a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The COST - Vendor Associate Director leads the end-to-end outsourcing of one or more indications and supports governance of external service providers for current and future clinical trials for multiple Development functions, with a strong emphasis on Clinical Vendors (e.g., CRO's, imaging, cardiac, IRT, data management, Pharmacovigilance, etc.) Responsibilities include partnering with the clinical operations and other functional teams for clinical vendor identification, creation of requests for information/proposal (RFIs/RFPs), service provider selection, contract negotiations, budget and contract lifecycle management, and facilitating service provider governance, including Key Performance Indicators (KPIs) and performance metrics. This position would report to the Senior Director, COST Vendor Team. The key responsibilities are: